Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin OTC Actual Use Study
NCT01726270Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamsulosin in lower urinary tract symptoms (LUTS), sponsored by Boehringer Ingelheim. Started Nov 2012; status: completed.
02
Drugs
tamsulosin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT01726270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726270.